- Report
- October 2022
- 100 Pages
Global
From €2188EUR$2,500USD£1,902GBP
- Report
- September 2022
- 288 Pages
Global
From €8314EUR$9,500USD£7,227GBP
- Report
- September 2022
- 239 Pages
Global
From €6564EUR$7,500USD£5,706GBP
- Report
- April 2020
- 80 Pages
Global
From €3457EUR$3,950USD£3,005GBP
- Report
- January 2025
- 140 Pages
Asia Pacific
From €3501EUR$4,000USD£3,043GBP
- Report
- December 2024
- 87 Pages
Spain
From €3063EUR$3,500USD£2,663GBP
- Report
- July 2024
- 80 Pages
Japan
From €3063EUR$3,500USD£2,663GBP
- Report
- November 2023
- 78 Pages
France
From €3063EUR$3,500USD£2,663GBP
- Report
- November 2023
- 78 Pages
Germany
From €3063EUR$3,500USD£2,663GBP
- Report
- November 2023
- 83 Pages
Germany
From €3063EUR$3,500USD£2,663GBP
- Report
- May 2024
- 182 Pages
Global
From €3938EUR$4,500USD£3,423GBP
- Report
- October 2023
- 73 Pages
Canada
From €3063EUR$3,500USD£2,663GBP
- Report
- May 2024
- 298 Pages
Global
From €6958EUR$7,950USD£6,048GBP
- Report
- May 2023
- 200 Pages
Global
From €6564EUR$7,500USD£5,706GBP
- Report
- May 2023
- 220 Pages
Global
From €2188EUR$2,500USD£1,902GBP
- Report
- May 2023
- 450 Pages
Global
From €4376EUR$5,000USD£3,804GBP
- Report
- February 2021
- 50 Pages
Global
From €2844EUR$3,250USD£2,473GBP
- Report
- December 2024
- 175 Pages
Global
From €4376EUR$5,000USD£3,804GBP
- Report
- June 2021
Global
From €3501EUR$4,000USD£3,043GBP
- Report
- February 2025
- 85 Pages
India
From €3063EUR$3,500USD£2,663GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more